Tissue Repair Ltd. is a clinical stage bio pharmaceutical company, which develops advanced wound healing products targeting applications in the chronic wound and aesthetic procedure aftercare markets, with the potential for further development of related technologies. The company has developed an ingredient that is designed for wound healing and the biologically active pharmaceutical ingredient behaves like a decoy cell that simulates a yeast infection, resulting in the stimulation of the body's own wound repair pathways. The company was founded by Tony Charara in 2012 and is headquartered in Sydney, Australia.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company